Printer Friendly

UNITED-GUARDIAN REPORTS RESULTS FOR THE FISCAL YEAR ENDED DEC. 31, 1991

UNITED-GUARDIAN REPORTS RESULTS FOR THE FISCAL YEAR ENDED DEC. 31, 1991
 HAUPPAUGE, N.Y., March 5 /PRNewswire/ -- United-Guardian, Inc. (AMEX: UG), today reported audited financial results for the ten-month fiscal year ended Dec. 31, 1991. Revenue for the ten-month period increased 39 percent from $3,603,019 to $5,008,823. Operating profits increased from a loss of $51,011 (unaudited) last year to a profit of $586,689 this year. Net earnings for the period increased from a loss last year of $(409,028), or $(.09) a share, to a profit of $458,782, or $.10 a share, a turnaround of $867,810.
 Alfred R. Globus, chairman and chief executive officer of United-Guardian, stated: "Despite the slow economy, the year-end figures confirm the dramatic turnaround of the company this past fiscal year. Substantial shipments to Schering-Plough that began in November in connection with the introduction of its new Gyne-Moistrin product were responsible for a substantial increase in revenue in the fourth quarter."
 Globus also indicated that the company is making progress with its increased marketing efforts for several other products, including the negotiation of worldwide licenses for the use of one of its microbicidal products, Clorpactin WCS-90, as a replacement for antibiotics in the treatment of mastitis in dairy cows.
 United-Guardian is a manufacturer of pharmaceuticals, health care products, medical devices and cosmetic bases.
 UNITED-GUARDIAN, INC.
 Ten-month fiscal year 1991 1990
 ended Dec. 31 (A) (Unaudited)
 Revenue $5,008,823 $3,603,019
 Operating profit 586,689 (51,011)
 Net earnings (loss) from cont. opers. (B) 478,529 (201,471)
 Net earnings (loss) from discont. opers. -- (207,177)
 Provision for income taxes 180,477 380
 Extraordinary tax credit 160,700 --
 Net earnings (loss) 458,782 (409,028)
 Share earnings (loss) from cont. opers. $.06 $(.04)
 Share earnings (loss) from discont. opers. -- (.05)
 Share earnings from extraord. tax credit .04 --
 Net share earnings (loss) $.10 $(.09)
 Shares outstanding 4,762,889 4,762,889
 (A) -- During the past fiscal year the company changed its fiscal year end from Feb. 28 to Dec. 31. The results for both fiscal years are for the ten-month period from March 1 to Dec. 31.
 (B) -- Before provision for income taxes and extraordinary tax credit.
 -0- 3/5/92
 /CONTACT: Robert S. Rubinger of United-Guardian, 516-273-0900/
 (UG) CO: United-Guardian, Inc. ST: New York IN: MTC SU: ERN


TS-GK -- NY007 -- 5281 03/05/92 08:47 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 5, 1992
Words:401
Previous Article:NORTH AMERICAN BIOLOGICALS REPORTS YEAR-END 1991 RESULTS
Next Article:OHM CORPORATION ANNOUNCES $10 MILLION CONTRACT AWARD
Topics:


Related Articles
UNITED-GUARDIAN REPORTS THREE MONTH RESULTS
UNITED-GUARDIAN APPOINTS ARTHUR ANDERSEN
FOREST LABORATORIES REPORTS RECORD FISCAL THIRD QUARTER RESULTS
R.P. SCHERER REPORTS THIRD-QUARTER FINANCIAL RESULTS
SPI PHARMACEUTICALS REPORTS RECORD NET INCOME AND SALES FOR THE YEAR ENDED 1991
ROBERTS PHARMACEUTICAL REPORTS 1991 RESULTS
UNITED-GUARDIAN REPORTS FIRST QUARTER RESULTS
UNITED-GUARDIAN REPORTS SECOND QUARTER RESULTS
UNITED-GUARDIAN, INC. REPORTS NINE MONTH RESULTS
UNITED-GUARDIAN REPORTS FISCAL YEAR 1992 EARNINGS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters